Notice to Prescribers
Updates to BC-CfE HIV Drug Treatment and Prevention Programs
Formulary Addition: Dolutegravir-lamivudine (Dovato®) Resumption of routine HIV plasma viral load testing Updates to BC-CfE Guidance Documents
Updates to BC-CfE HIV Drug Treatment and Prevention Programs Read More »
Updated BC-CfE Reference Documents Available for Use
Click here to link to Therapeutic Guidelines for Antiretroviral (ARV) Treatment of Adult HIV Infection Click here to link to Guidance for the use of Pre-Exposure Prophylaxis (PrEP) for the prevention of HIV acquisition in British Columbia
Updated BC-CfE Reference Documents Available for Use Read More »
Dolutegravir-containing Products (Tivicay®, Triumeq®) in Pregnancy and Use in Women of Reproductive Age
For more information: click here to link to BC-CfE Drug Safety Alerts